TAG:
managed care contracting
Increased Competition For Hospital Lab Referrals
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
CEO SUMMARY: It’s a buyer’s market for hospital send-out testing because the supply of such tests exceeds demand. To fill excess capacity in their labs, some reference/esoteric lab companies are willing to offer rock-bottom prices to new clients. This situation is also motivating nati…
Some Random Insights About LabCorp’s Thinking
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
CEO SUMMARY: Having scooped up a number of mid-sized laboratory companies in recent years, Laboratory Corporation of America is working to integrate these operations and continue to expand its market share. In a recent conversation with financial analyst Bill Bonnello of Wachovia Securiti…
Payer Consolidation: WellPoint Buys into NYC
By Robert Michel | From the Volume XII No. 15 – October 24, 2005 Issue
CEO SUMMARY: Acquisition by acquisition, the health insurance industry is consolidating. Wellpoint, Inc., already the nation’s largest health insurer at 28 million members, is acquiring WellChoice, Inc. and adding another 5 million members to its total. One consequence of this consolida…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
Change Beneath Surface Marks 2004 Lab Stories
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2004.” These are the events we consider most important to the lab industry during the year. However, in contrast to past years, 2004 lacked the types of blockbuster events which radically change and reshap…
Physician Group Path Ventures To Undergo OIG Review in 2005
By Robert Michel | From the Volume XI No. 15 – November 1, 2004 Issue
IN ITS FISCAL YEAR 2005 WORK PLAN, the Department of Health and Human Services (DHHS) Office of Inspector General (OIG) will “identify and review relationships between physicians who furnish pathology services in their offices and outside pathology companies.” I…
How Local Path Groups Can Keep Patient Access
By Robert Michel | From the Volume XI No.13 – September 20, 2004 Issue
CEO SUMMARY: For pathology groups operating their own histology and cytology labs, a growing problem is access to patients covered by exclusive managed care contracts. In the Northeast, several persistent pathology group practices are using some effective business strategies to fight this…
Why There’s “Bad Blood” Against National Labs
By R. Lewis Dark | From the Volume X No. 1 – January 20, 2003 Issue
I AM FREQUENTLY ASKED BY WALL STREET TYPES why there seems to be latent, even deep-seated animosity between a large number of local laboratories and both of the two blood brothers. They wonder why, for example, hospital laboratories aren’t more interested in doing collaborative ventures with either…
Big Premium Increases Drive Higher Profits at Nation’s HMOs
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
EVEN AS EMPLOYERS COMPLAIN about spiraling healthcare costs, the nation’s biggest health insurers are enjoying robust profits. That brings up the interesting question about whether providers, including laboratories, can get better pricing during the next year, since HMOs are again profita…
Two New Public Labs Launch Operations in FL
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
CEO SUMMARY: In 49 states, independent commercial laboratory companies are disappearing. But that’s not the case in Florida. In recent months, two new public laboratory companies completed organizational steps and now offer diagnostic testing services. Both companies are starting small,…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized